A disease‐specific decline of the relative abundance of Bifidobacterium in patients with autoimmune hepatitis

The pathogenesis of autoimmune hepatitis (AIH) is poorly understood and little is known about enteric microbiota in AIH.

[1]  W. Lieb,et al.  Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis , 2019, Alimentary pharmacology & therapeutics.

[2]  Bo Li,et al.  Alterations of gut microbiome in autoimmune hepatitis , 2019, Gut.

[3]  Lanjuan Li,et al.  Bifidobacterium adolescentis CGMCC 15058 alleviates liver injury, enhances the intestinal barrier and modifies the gut microbiota in d-galactosamine-treated rats , 2018, Applied Microbiology and Biotechnology.

[4]  Guoyao Wu,et al.  Dietary supplementation with an amino acid blend enhances intestinal function in piglets , 2018, Amino Acids.

[5]  Dong-Hyun Kim,et al.  Simultaneous Amelioratation of Colitis and Liver Injury in Mice by Bifidobacterium longum LC67 and Lactobacillus plantarum LC27 , 2018, Scientific Reports.

[6]  M. Manns,et al.  Autoimmune hepatitis , 2018, Nature Reviews Disease Primers.

[7]  Li Chen,et al.  GMPR: A robust normalization method for zero-inflated count data with application to microbiome sequencing data , 2018, PeerJ.

[8]  D. Jain,et al.  Translocation of a gut pathobiont drives autoimmunity in mice and humans , 2018, Science.

[9]  J. Segre,et al.  Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation , 2017, Science.

[10]  A. Bäumler,et al.  Dysbiotic Proteobacteria expansion: a microbial signature of epithelial dysfunction. , 2017, Current opinion in microbiology.

[11]  Yating Li,et al.  Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota , 2017, Scientific Reports.

[12]  S. Delgado,et al.  Bifidobacteria and Their Health-Promoting Effects. , 2017, Microbiology spectrum.

[13]  C. Langner,et al.  Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. , 2017, Journal of Crohn's & colitis.

[14]  Jing-Yuan Fang,et al.  Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy , 2017, Gut.

[15]  S. Duncan,et al.  Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics , 2017, The ISME Journal.

[16]  U. Nöthlings,et al.  Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota , 2016, Nature Genetics.

[17]  A. Levin,et al.  Neonatal gut microbiota associates with childhood multi–sensitized atopy and T–cell differentiation , 2016, Nature Medicine.

[18]  D. Aguirre de Cárcer,et al.  Colonic microbiota can promote rapid local improvement of murine colitis by thioguanine independently of T lymphocytes and host metabolism , 2016, Gut.

[19]  Paul J. McMurdie,et al.  DADA2: High resolution sample inference from Illumina amplicon data , 2016, Nature Methods.

[20]  T. Karlsen,et al.  The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls , 2016, Gut.

[21]  A. Margolles,et al.  Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health , 2016, Front. Microbiol..

[22]  James Kinross,et al.  The gut microbiota and host health: a new clinical frontier , 2015, Gut.

[23]  Wei Xu,et al.  Assessment and Selection of Competing Models for Zero-Inflated Microbiome Data , 2015, PloS one.

[24]  Jorge Henao-Mejia,et al.  Role of the intestinal microbiome in liver disease. , 2013, Journal of autoimmunity.

[25]  U. Nöthlings,et al.  Fitting portion sizes in a self-administered food frequency questionnaire. , 2007, The Journal of nutrition.

[26]  Garry D. Peterson,et al.  Response diversity, ecosystem change, and resilience , 2003 .

[27]  N. Graham,et al.  Areas beneath the relative operating characteristics (ROC) and relative operating levels (ROL) curves: Statistical significance and interpretation , 2002 .

[28]  E. Hermann-Kunz,et al.  The German Food Code and Nutrient Data Base (BLS II.2) , 1999, European Journal of Epidemiology.

[29]  M. Dumont,et al.  European Association for the Study of the Liver , 1971 .

[30]  J. Drenth.  EASL Clinical Practice Guidelines: Autoimmune hepatitis. , 2015, Journal of hepatology.

[31]  F. Lammert,et al.  EASL Clinical Practice Guidelines: management of cholestatic liver diseases. , 2009, Journal of hepatology.

[32]  P. Legendre,et al.  vegan : Community Ecology Package. R package version 1.8-5 , 2007 .

[33]  S. Salminen,et al.  Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. , 2001, The Journal of allergy and clinical immunology.